Interpace Biosciences (IDXG) Debt to Equity Ratio

Price: $2.005
Market Cap: $8.83M
Avg Volume: 7.93K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 0.669
52W Range: $1.01-2.08
Website: Interpace Biosciences

Debt to Equity Ratio

Interpace Biosciences's debt to equity ratio indicates the proportion of equity and debt the company uses to finance its assets:

  • Annual: -0.64
  • Quarterly: -0.67
  • TTM: -0.67

Other Key Debt Metrics

These metrics provide additional insights into Interpace Biosciences's financial leverage and its ability to meet financial obligations:

  • Debt Ratio - indicates the proportion of a company's assets that are financed through debt:
    • Annual: 74.65%
    • Quarterly: 64.67%
    • TTM: 64.67%
  • Debt to Assets Ratio - shows the proportion of a company's assets that are financed by debt:
    • Annual: 74.65%
    • Quarterly: 64.67%
    • TTM: 64.67%

These financial metrics offer a comprehensive view of Interpace Biosciences's debt structure and financial health. By comparing these ratios with industry benchmarks, investors can better understand the company's leverage and risk profile.

Annual Debt to Equity Ratio

-0.64

Quarterly Debt to Equity Ratio

-0.67

TTM Debt to Equity Ratio

-0.67

Interpace Biosciences Historical Debt to Equity Ratio
Historical Debt Ratio
Historical Debt to Assets Ratio

Interpace Biosciences Historical Debt to Equity Ratio

The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2023.

Year Debt to Equity Ratio Debt Ratio Debt to Assets Ratio
2023 -0.64 74.65% 74.65%
2022 -0.26 100.70% 100.70%
2021 -0.32 35.69% 35.69%
2020 -0.16 10.39% 10.39%
2019 0.54 10.28% 10.28%
2018 0.00 0.00% 0.00%
2017 0.00 0.00% 0.00%
2016 1.21 18.93% 18.93%
2015 0.64 12.40% 12.40%
2014 2.33 40.42% 40.42%